Azenta, Inc.

NasdaqGS:AZTA 주식 보고서

시가총액: US$2.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Azenta 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

John P. Marotta

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간1.7yrs
이사회 평균 재임 기간2.3yrs

최근 관리 업데이트

Recent updates

Azenta: Life Science Play Is Not Coming To Life

Sep 11

Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Jul 19
Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Apr 27
Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Apr 05
Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Dec 28
Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

Nov 07
Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Sep 13
At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Aug 09
Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Jun 01
Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

May 11
Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

Is Azenta, Inc. (NASDAQ:AZTA) Worth US$42.5 Based On Its Intrinsic Value?

Mar 30
Is Azenta, Inc. (NASDAQ:AZTA) Worth US$42.5 Based On Its Intrinsic Value?

Azenta: Putting Its Cash Hoard To Use

Oct 02

Azenta to acquire vaccine cold chain firm B Medical Systems for €410M

Aug 08

Brasada Capital - Azenta Life Sciences: No Ordinary Company

Jul 26

CEO

John P. Marotta (43 yo)

no data

테뉴어

Mr. John P. Marotta is President & CEO of Azenta, Inc. from September 9, 2024. Mr. Marotta serves as Executive in Residence at Patient Square Capital, LP since joining the firm in March 16, 2023. He levera...


리더십 팀

이름위치테뉴어보상소유권
Robin Vacha
Senior Vice President of Global Operationsno dataUS$1.43m0.048%
$ 1.2m
Jason Joseph
Senior VP13.5yrsUS$1.44m0.20%
$ 4.9m
John P. Marotta
President & CEOno data데이터 없음데이터 없음
Herman Cueto
Executive VP & CFOless than a year데이터 없음데이터 없음
Violetta Hughes
VP & Chief Accounting Officer1.1yrs데이터 없음0%
$ 0
Michael Paulo
VP and Chief Information & Digital Officer7.2yrs데이터 없음데이터 없음
John O'Brien
Senior Vice President of Corporate Development14.3yrs데이터 없음데이터 없음
Olga Pirogova
Senior VP & Chief HR Officer1.1yrs데이터 없음데이터 없음
J. Woodward
Senior Vice President of Global Quality & Regulatory14.8yrs데이터 없음데이터 없음
Ginger Zhou
Senior VP & GM of Multiomics and Synthesis Solutions5.3yrs데이터 없음0.017%
$ 421.7k
David Wang
Senior VP & GM of Sample Management Solutions1.7yrs데이터 없음0.011%
$ 263.3k
Luc Provost
VP & CEO of B Medical Systemsless than a year데이터 없음데이터 없음

1.7yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 관리: AZTA 의 관리팀은 경험 (평균 재직 기간 1.7 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Tina Nova
Independent Director1.7yrsUS$207.50k0.012%
$ 299.8k
Michael Rosenblatt
Independent Director6yrsUS$260.00k0.027%
$ 644.0k
Martin Madaus
Independent Directorless than a year데이터 없음0.0050%
$ 121.7k
Didier Hirsch
Independent Directorless than a year데이터 없음0.0050%
$ 121.7k
Edward Bousa
Independent Directorless than a year데이터 없음0.0050%
$ 121.7k
Robyn Davis
Independent Vice Chair of the Board11.3yrsUS$278.75k0.060%
$ 1.5m
Erica McLaughlin
Independent Director4.4yrsUS$273.75k0.026%
$ 632.8k
Frank Casal
Independent Chairman2.8yrsUS$275.00k0.019%
$ 463.8k

2.3yrs

평균 재임 기간

67.5yo

평균 연령

경험이 풍부한 이사회: AZTA 의 이사회경험(평균 재직 기간 2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.